No profile data available.
RetinalGenix Technologies Inc. (RTGN) is a healthcare company in the targeted healthcare equipment industry, based in Apollo Beach, United States.
It reported revenue of $0 for fiscal year 2025, and net income of -$2.43 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $75.19 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
, an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders.
RetinalGenix Technologies reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$75.19 million as of October 8, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Lensar, Inc. (LNSR), Pulmonx Corporation (LUNG), Outset Medical, Inc. (OM), Microbot Medical Inc. (MBOT).